Fresenius Medical Care AG & Co KGaA ADR buy Societe Generale
Start price
17.11.23
/
50%
€17.70
Target price
17.11.24
-
Performance (%)
15.25%
End price
18.11.24
€20.40
Summary
This prediction ended on 18.11.24 with a price of €20.40. The prediction had a final performance of 15.25%. A total of €0.58 was paid as dividends for this prediction. Societe_Generale has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fresenius Medical Care AG & Co KGaA ADR | -6.633% | -6.633% | -16.818% |
| iShares Core DAX® | -1.875% | 2.861% | 18.863% |
| iShares Nasdaq 100 | -2.177% | 0.048% | 3.956% |
| iShares Nikkei 225® | -0.867% | 6.987% | 21.062% |
| iShares S&P 500 | -1.253% | 1.248% | 2.246% |
Comments by Societe_Generale for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ADR diskutieren
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) was upgraded by analysts at Societe Generale from a "hold" rating to a "buy" rating.
Ratings data for FMS provided by MarketBeat
In the thread Trading Fresenius Medical Care AG & Co KGaA ADR
Die von Societe_Generale gewählte maximale Laufzeit wurde überschritten